Beijing is a global leader in advanced medicine, with the top 5 hospitals in Beijing for CAR-T therapy including Peking University Cancer Hospital, Chinese Academy of Medical Sciences Cancer Hospital, and Peking Union Medical College Hospital. These centers excel in complex “dual-target” CAR-T and pioneering solid tumor trials, offering unparalleled expertise at a CAR-T cell therapy cost in China that is significantly more accessible than Western alternatives.
Key Facts
- CAR-T therapy in Beijing costs $80,000—$160,000 USD in 2026, depending on hospital and treatment complexity — a fraction of Western pricing.
- Beijing GoBroad Boren Hospital has performed over 4,000 CAR-T infusions, specializing in dual-target CD19+CD22 approaches for leukemia and lymphoma.
- Peking Union Medical College Hospital (PUMCH) is ranked the #1 hospital in China, integrating CAR-T with management of complex co-morbidities.
- CAR-T manufacturing timelines range from 7—21 days; patients typically remain in Beijing for the full inpatient infusion and monitoring period.
- Beijing is the only city in China where Peking University Cancer Hospital, PUMCH, Lu Daopei Hospital, and GoBroad Boren Hospital are all accessible within the same metropolitan area.
Table of Contents
Why Choose Beijing for CAR-T?
Beijing’s prestigious medical universities serve as centers for national CAR-T research and guideline development, giving patients access to leading specialists. As China’s capital, Beijing concentrates the highest density of nationally ranked oncology institutions, making it one of the premier destinations globally for cellular immunotherapy. CAR-T cell therapy involves collecting a patient’s T cells, genetically engineering them to target cancer cells, and reinfusing them — a process that has achieved remission in patients with relapsed or refractory hematologic malignancies.
The Top 5 Hospitals in Beijing for CAR-T Therapy Profiles
1. Peking University Cancer Hospital
Peking University Cancer Hospital is consistently ranked among the top cancer centers worldwide. It’s a national leader in clinical research, particularly for lymphoma and innovative CAR-T trials targeting solid tumors like gastric cancer (e.g., Claudin 18.2).
- Specialty: Complex lymphoma cases and solid tumor trials, including gastric cancer targeting Claudin 18.2
- International services: Dedicated International Medical Center
- Official Site: PKU Cancer Hospital
- Estimated cost: $90,000—$130,000 USD
2. Beijing GoBroad Hospital
The success rates at the top 5 hospitals in Beijing for CAR-T therapy are impressive, reflecting their dedication to innovation and patient care.
With over 4,000 CAR-T infusions a year, Beijing GoBroad Hospital is among the top 5 hospitals in Beijing for CAR-T therapy, known for its exceptional patient outcomes.
Beijing GoBroad Hospital is a specialized private hospital that has performed over 4,000 CAR-T infusions by 2026, making it one of the most experienced centers globally. They are renowned for their high success rates in “dual-target” CAR-T (e.g., CD19 + CD22) for relapsed/refractory leukemia and lymphoma.
- Specialty: Dual-target CAR-T (CD19 + CD22) for leukemia and lymphoma
- Notable: Over 4,000 CAR-T infusions performed
- International services: English-speaking patient coordinators, visa support
- Official Site: GoBroad Healthcare Group
- Estimated cost: $80,000—$110,000 USD
3. Peking Union Medical College Hospital (PUMCH)
Consistently ranked as the #1 hospital in China, PUMCH is often considered the “court of final appeal” for the most challenging medical cases. While not exclusively a CAR-T center, its hematology department integrates CAR-T with its unparalleled expertise in managing complex patient co-morbidities.
- Specialty: CAR-T integrated with management of complex co-morbidities
- Notable: Ranked #1 hospital in China
- International services: International Medical Department
- Official Site: PUMCH
Peking Union Medical College Hospital is also listed among the top 5 hospitals in Beijing for CAR-T therapy, offering a unique blend of expertise and advanced technology.
4. Lu Daopei Hospital (Beijing Center)
Founded by the “Father of Chinese Bone Marrow Transplantation,” Lu Daopei Hospital is a powerhouse in hematologic malignancies. They are experts at integrating CAR-T as a “bridge to transplant,” ensuring patients achieve minimal residual disease (MRD) negativity before a life-saving bone marrow transplant.
- Specialty: CAR-T as a “bridge to transplant” strategy; expert in hematologic malignancies
- Official Site: Lu Daopei Hospital
For those considering CAR-T therapy, Lu Daopei Hospital remains one of the top 5 hospitals in Beijing for CAR-T therapy, focusing on hematologic malignancies.
5. Beijing United Family Hospital (BJU)
Beijing United Family Hospital offers a premium, Western-style patient experience. While they often collaborate with leading Chinese CAR-T centers for cell manufacturing, BJU provides the JCI-accredited inpatient care and post-infusion monitoring in a 100% English-speaking environment.
- Specialty: Premium Western-style patient experience with JCI-accredited inpatient care
- International services: 100% English-speaking environment
- Official Site: United Family Healthcare
- Estimated cost: $120,000—$160,000 USD
💡 You may like: CAR-T Treatment Timeline in China: 2026 Step-by-Step Guide for Patients
Lastly, Beijing United Family Hospital is recognized in the top 5 hospitals in Beijing for CAR-T therapy, providing a premium patient experience in a welcoming environment.
Cost & Success Rates in Beijing (2026 Estimate)
The car t cell therapy cost in china in Beijing offers significant value compared to Western markets, allowing more patients to access these life-saving therapies.
Hospital | Estimated Total Cost (USD) |
|---|---|
| Peking University Cancer Hospital | $90,000—$130,000 |
| Beijing GoBroad Boren Hospital | $80,000—$110,000 |
| Peking Union Medical College Hospital | Available on assessment |
| Lu Daopei Hospital | Available on assessment |
| Beijing United Family Hospital | $120,000—$160,000 |
| General Beijing range | $80,000—$160,000 |
CAR-T therapy in Beijing addresses leukemia, lymphoma, and select solid tumor clinical trials, including gastric cancer. The FDA has approved several CAR-T products for lymphoma, establishing the clinical benchmark against which China’s programs are measured.
Travel Logistics: Arriving in Beijing
Beijing is served by two major international airports: Beijing Capital International Airport (PEK) and Beijing Daxing International Airport (PKX). Major hospitals arrange private transport from either airport for international patients.
Ready to Explore Your CAR-T Options in Beijing?
Navigating the complexities of international medical treatment can be daunting. If you’re considering one of Beijing’s top CAR-T hospitals, or just want to understand your eligibility and car t cell therapy cost in china for your specific case, I’m here to help.
When choosing from the top 5 hospitals in Beijing for CAR-T therapy, consider the specialized services they offer and their track record in patient care. Exploring your options at the top 5 hospitals in Beijing for CAR-T therapy can lead you to the most effective treatment for your condition.
Get a Free Case Assessment | View CAR-T Cell Therapy in China | Compare CAR-T Costs: China vs USA
Let’s chat about your medical records, visa process, and how to get you to the right specialist in Beijing. I’m usually available for quick replies during Beijing business hours!
FAQs
1. Is CAR-T therapy available for international patients in Beijing?
Yes. Major hospitals in Beijing such as Peking University Cancer Hospital and Beijing GoBroad Boren Hospital provide CAR-T therapy for international patients with structured medical visa support. According to the WHO, cancer accounts for nearly 10 million deaths annually, driving growing demand for advanced treatments like CAR-T across borders.
2. What is the estimated CAR-T therapy cost in Beijing?
Depending on the hospital and treatment complexity, CAR-T therapy in Beijing typically ranges between $80,000 and $160,000 USD.
3. What cancers are commonly treated with CAR-T therapy in Beijing?
CAR-T therapy in Beijing is commonly used for leukemia, lymphoma, and certain solid tumor clinical trials such as gastric cancer.
